SF1-PitNETs harbor tumor-associated stem cells with multilineage endocrine potential

The existence of cells expressing stem cell or cancer stem cell markers has been demonstrated and is widely accepted across all subtypes of pituitary neuroendocrine tumors (PitNETs). This observation underscores the potential role and active contribution of a stem cell population to pituitary tumorigenesis. It also raises the question of whether pituitary tumor behavior and the recent identification of plurihormonal PitNETs, may involve or reflect the influence of tumor-associated stem cells with intrinsic capacities for self-renewal or endocrine differentiation. Here, we combined histological, single-cell, and spatial transcriptomic approaches with functional analyses of patient-derived pituispheres to refine our understanding of SOX2-expressing cells in SF1-PitNETs. Our analyses confirm that SOX2⁺ cells are rare and heterogeneously distributed in SF1-PitNETs. We delineate two principal SOX2⁺/SOX9⁺ stem cell populations: one expressing folliculostellate markers (S100B, GFAP, VIM) and the other enriched for canonical cancer stem cell markers (CD133, CD44, CD24). Pseudotime trajectory analysis indicates that CD133⁺/SOX2⁺/SOX9⁺ cells are poised for endocrine differentiation, supported by the identification of transitional cells co-expressing cytoplasm-localized SOX2 and transcription factors of the three major pituitary endocrine lineages. Our results further suggest a potential role for STAT3 signaling in the maintenance and commitment to endocrine differentiation of these tumor-associated cells. These findings support that pituitary tumor behavior is not solely driven by the proliferation of differentiated endocrine cells but may also involve a population of tumor-associated stem cells capable of multilineage differentiation.

Authors

Institutions

Publication Details

Journal
Acta Neuropathologica Communications
Published
2026-11-19
DOI
https://doi.org/10.1186/s40478-026-02483-9
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

SF1-PitNETs harbor tumor-associated stem cells with multilineage endocrine potential

Marie Chanal, Mirela Diana Ilie, Raul Miguel Luque, Francisco Porcel-Pastrana et al.
Acta Neuropathologica Communications
Pituitary Gland Disorders and Treatments
article

SF1-PitNETs harbor tumor-associated stem cells with multilineage endocrine potential

Marie Chanal, Mirela Diana Ilie, Raul Miguel Luque, Francisco Porcel-Pastrana, Alexandre Vasiljevic, Camille Charrondière, Philippe Bertolino, Gérald Raverot, David Bernard, Franck Picard, Laura Chinezu, Álvaro Flores‐Martínez, Emmanuel Jouanneau, Benoît Samson, Ayoub Lehiani
article en

Abstract

The existence of cells expressing stem cell or cancer stem cell markers has been demonstrated and is widely accepted across all subtypes of pituitary neuroendocrine tumors (PitNETs). This observation underscores the potential role and active contribution of a stem cell population to pituitary tumorigenesis. It also raises the question of whether pituitary tumor behavior and the recent identification of plurihormonal PitNETs, may involve or reflect the influence of tumor-associated stem cells with intrinsic capacities for self-renewal or endocrine differentiation. Here, we combined histological, single-cell, and spatial transcriptomic approaches with functional analyses of patient-derived pituispheres to refine our understanding of SOX2-expressing cells in SF1-PitNETs. Our analyses confirm that SOX2⁺ cells are rare and heterogeneously distributed in SF1-PitNETs. We delineate two principal SOX2⁺/SOX9⁺ stem cell populations: one expressing folliculostellate markers (S100B, GFAP, VIM) and the other enriched for canonical cancer stem cell markers (CD133, CD44, CD24). Pseudotime trajectory analysis indicates that CD133⁺/SOX2⁺/SOX9⁺ cells are poised for endocrine differentiation, supported by the identification of transitional cells co-expressing cytoplasm-localized SOX2 and transcription factors of the three major pituitary endocrine lineages. Our results further suggest a potential role for STAT3 signaling in the maintenance and commitment to endocrine differentiation of these tumor-associated cells. These findings support that pituitary tumor behavior is not solely driven by the proliferation of differentiated endocrine cells but may also involve a population of tumor-associated stem cells capable of multilineage differentiation.

Acta Neuropathologica Communications
Université Claude Bernard Lyon 1 (FR), École Normale Supérieure de Lyon (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Carol Davila University of Medicine and Pharmacy (RO), Instituto de Salud Carlos III (ES), Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO), Instituto Maimónides de Investigación Biomédica de Córdoba (ES), Hospices Civils de Lyon (FR), Laboratoire de Biologie et Modélisation de la Cellule (FR), Centro de Investigación Biomédica en Red (ES), Centre de Recherche en Cancérologie de Lyon (FR), University of Córdoba (ES)
Pituitary Gland Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon